Valid for Submission
D25.1 is a billable diagnosis code used to specify a medical diagnosis of intramural leiomyoma of uterus. The code D25.1 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D25.1 might also be used to specify conditions or terms like abnormal uterine bleeding due to intramural uterine fibroid, abnormal uterine bleeding due to uterine fibroid, benign neoplasm of body of uterus, benign neoplasm of myometrium or intramural leiomyoma of uterus.
The code D25.1 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D25.1:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Interstitial leiomyoma of uterus
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D25.1 are found in the index:
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Abnormal uterine bleeding due to intramural uterine fibroid
- Abnormal uterine bleeding due to uterine fibroid
- Benign neoplasm of body of uterus
- Benign neoplasm of myometrium
- Intramural leiomyoma of uterus
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|742||UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC||13||1.717|
|743||UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC||13||1.1323|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D25.1 to ICD-9 Code
Information for Patients
Uterine fibroids are the most common benign tumors in women of childbearing age. Fibroids are made of muscle cells and other tissues that grow in and around the wall of the uterus, or womb. The cause of fibroids is unknown. Risk factors include being African American or being overweight.
Many women with fibroids have no symptoms. If you do have symptoms, they may include
- Heavy or painful periods or bleeding between periods
- Feeling "full" in the lower abdomen
- Urinating often
- Pain during sex
- Lower back pain
- Reproductive problems, such as infertility, multiple miscarriages or early labor
Your health care provider may find fibroids during a gynecological exam or by using imaging tests. Treatment includes drugs that can slow or stop their growth, or surgery. If you have no symptoms, you may not even need treatment. Many women with fibroids can get pregnant naturally. For those who cannot, infertility treatments may help.
NIH: National Institute of Child Health and Human Development
[Learn More in MedlinePlus]